MedTrace Logo

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

NCT01569906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2012-04-05

No results posted yet for this study

Summary

To assess prospectively, the response of moderate to severe atopic eczema to a standard course of narrowband ultraviolet B phototherapy by using validated objective and subjective scoring systems.

Conditions

  • Moderate to Severe Atopic Eczema

Interventions

RADIATION

Narrowband Ultraviolet B phototherapy

Twice weekly exposures for a total of 24 exposures using a standard phototherapy protocol.

Sponsors & Collaborators

  • British Skin Foundation

    collaborator UNKNOWN

  • Royal Victoria Infirmary

    lead OTHER

Principal Investigators

  • Aileen EM Taylor, MBChB · Royal Victoria Infirmary

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569906 on ClinicalTrials.gov